Literature DB >> 28229302

Tremor analysis separates Parkinson's disease and dopamine receptor blockers induced parkinsonism.

Aasef G Shaikh1,2,3,4.   

Abstract

Parkinson's disease, the most common cause of parkinsonism is often difficult to distinguish from its second most common etiology due to exposure to dopamine receptor blocking agents such as antiemetics and neuroleptics. Dual axis accelerometry was used to quantify tremor in 158 patients with parkinsonism; 62 had Parkinson's disease and 96 were clinically diagnosed with dopamine receptor blocking agent-induced parkinsonism. Tremor was measured while subjects rested arms (resting tremor), outstretched arms in front (postural tremor), and reached a target (kinetic tremor). Cycle-by-cycle analysis was performed to measure cycle duration, oscillation amplitude, and inter-cycle variations in the frequency. Patients with dopamine receptor blocker induced parkinsonism had lower resting and postural tremor amplitude. There was a substantial increase of kinetic tremor amplitude in both disorders. Postural and resting tremor in subjects with dopamine receptor blocking agent-induced parkinsonism was prominent in the abduction-adduction plane. In contrast, the Parkinson's disease tremor had equal amplitude in all three planes of motion. Tremor frequency was comparable in both groups. Remarkable variability in the width of the oscillatory cycles suggested irregularity in the oscillatory waveforms in both subtypes of parkinsonism. Quantitative tremor analysis can distinguish Parkinson's disease from dopamine receptor blocking agent-induced parkinsonism.

Entities:  

Keywords:  Basal ganglia; Neuroleptic; Oscillations; Tardive

Mesh:

Substances:

Year:  2017        PMID: 28229302     DOI: 10.1007/s10072-017-2852-6

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  17 in total

1.  Olfactory loss may be a first sign of idiopathic Parkinson's disease.

Authors:  Antje Haehner; Thomas Hummel; Cornelia Hummel; Ulrike Sommer; Susann Junghanns; Heinz Reichmann
Journal:  Mov Disord       Date:  2007-04-30       Impact factor: 10.338

Review 2.  When does Parkinson disease start?

Authors:  Rodolfo Savica; Walter A Rocca; J Eric Ahlskog
Journal:  Arch Neurol       Date:  2010-07

3.  Parkinson's disease - how do sleep and dementia interact?

Authors:  Ronald B Postuma; Jean-Francois Gagnon
Journal:  Sleep Med       Date:  2013-01-10       Impact factor: 3.492

4.  Persistent and progressive parkinsonism after discontinuation of chronic neuroleptic therapy: an additional tardive syndrome?

Authors:  E Melamed; A Achiron; A Shapira; S Davidovicz
Journal:  Clin Neuropharmacol       Date:  1991-06       Impact factor: 1.592

5.  Keeping your head on target.

Authors:  Aasef G Shaikh; Aaron L Wong; David S Zee; H A Jinnah
Journal:  J Neurosci       Date:  2013-07-03       Impact factor: 6.167

6.  Clinical characteristics of neuroleptic-induced parkinsonism.

Authors:  S Hassin-Baer; P Sirota; A D Korczyn; T A Treves; B Epstein; H Shabtai; T Martin; Y Litvinjuk; N Giladi
Journal:  J Neural Transm (Vienna)       Date:  2001       Impact factor: 3.575

7.  Prodromal autonomic symptoms and signs in Parkinson's disease and dementia with Lewy bodies.

Authors:  Ronald B Postuma; Jean-Francois Gagnon; Amélie Pelletier; Jacques Montplaisir
Journal:  Mov Disord       Date:  2013-03-28       Impact factor: 10.338

Review 8.  DAT imaging in drug-induced and psychogenic parkinsonism.

Authors:  Eduardo Tolosa; Miguel Coelho; Marisol Gallardo
Journal:  Mov Disord       Date:  2003-10       Impact factor: 10.338

9.  Drug-induced parkinsonism.

Authors:  Hae-Won Shin; Sun Ju Chung
Journal:  J Clin Neurol       Date:  2012-03-31       Impact factor: 3.077

10.  Tardive Syndromes are Rarely Reversible after Discontinuing Dopamine Receptor Blocking Agents: Experience from a University-based Movement Disorder Clinic.

Authors:  Deepti Zutshi; Leslie J Cloud; Stewart A Factor
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2014-10-23
View more
  1 in total

1.  News on the journal Neurological Sciences in 2017.

Authors:  Ilaria Di Donato; Antonio Federico
Journal:  Neurol Sci       Date:  2018-01       Impact factor: 3.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.